$2.59T
Total marketcap
$167.51B
Total volume
BTC 50.07%     ETH 15.77%
Dominance

AbCellera Biologics ABCL Stock

4.59 USD {{ price }} -2.547768% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
1.34B USD
LOW - HIGH [24H]
4.53 - 4.73 USD
VOLUME [24H]
1.09M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.51 USD

AbCellera Biologics Price Chart

AbCellera Biologics ABCL Financial and Trading Overview

AbCellera Biologics stock price 4.59 USD
Previous Close 7.39 USD
Open 7.35 USD
Bid 0 USD x 2200
Ask 0 USD x 1200
Day's Range 7.29 - 7.49 USD
52 Week Range 5.53 - 14.97 USD
Volume 1.96M USD
Avg. Volume 2.2M USD
Market Cap 2.16B USD
Beta (5Y Monthly) -0.124135
PE Ratio (TTM) N/A
EPS (TTM) -0.51 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 26.5 USD

ABCL Valuation Measures

Enterprise Value 1.33B USD
Trailing P/E N/A
Forward P/E -12.466666
PEG Ratio (5 yr expected) -1.38
Price/Sales (ttm) 11.929656
Price/Book (mrq) 1.7852029
Enterprise Value/Revenue 7.367
Enterprise Value/EBITDA -30.344

Trading Information

AbCellera Biologics Stock Price History

Beta (5Y Monthly) -0.124135
52-Week Change -26.086%
S&P500 52-Week Change 20.43%
52 Week High 14.97 USD
52 Week Low 5.53 USD
50-Day Moving Average 6.77 USD
200-Day Moving Average 9.42 USD

ABCL Share Statistics

Avg. Volume (3 month) 2.2M USD
Avg. Daily Volume (10-Days) 2.64M USD
Shares Outstanding 288.73M
Float 209.67M
Short Ratio 8.49
% Held by Insiders 28.64%
% Held by Institutions 46.47%
Shares Short 25.97M
Short % of Float 12.55%
Short % of Shares Outstanding 8.98%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -27.70%
Operating Margin (ttm) -40.49%
Gross Margin 13.85%
EBITDA Margin -24.27%

Management Effectiveness

Return on Assets (ttm) -2.96%
Return on Equity (ttm) -4.15%

Income Statement

Revenue (ttm) 181.04M USD
Revenue Per Share (ttm) 0.63 USD
Quarterly Revenue Growth (yoy) -96.099%
Gross Profit (ttm) 311.11M USD
EBITDA -43953000 USD
Net Income Avi to Common (ttm) -50164000 USD
Diluted EPS (ttm) -0.18
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 796.49M USD
Total Cash Per Share (mrq) 2.76 USD
Total Debt (mrq) 83.13M USD
Total Debt/Equity (mrq) 6.88 USD
Current Ratio (mrq) 10.499
Book Value Per Share (mrq) 4.19

Cash Flow Statement

Operating Cash Flow (ttm) 133.08M USD
Levered Free Cash Flow (ttm) 85.71M USD

Profile of AbCellera Biologics

Country United States
State BC
City Vancouver
Address 2215 Yukon Street
ZIP V5Y 0A1
Phone N/A
Website https://www.abcellera.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 525

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Q&A For AbCellera Biologics Stock

What is a current ABCL stock price?

AbCellera Biologics ABCL stock price today per share is 4.59 USD.

How to purchase AbCellera Biologics stock?

You can buy ABCL shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for AbCellera Biologics?

The stock symbol or ticker of AbCellera Biologics is ABCL.

Which industry does the AbCellera Biologics company belong to?

The AbCellera Biologics industry is Biotechnology.

How many shares does AbCellera Biologics have in circulation?

The max supply of AbCellera Biologics shares is 292.78M.

What is AbCellera Biologics Price to Earnings Ratio (PE Ratio)?

AbCellera Biologics PE Ratio is now.

What was AbCellera Biologics earnings per share over the trailing 12 months (TTM)?

AbCellera Biologics EPS is -0.51 USD over the trailing 12 months.

Which sector does the AbCellera Biologics company belong to?

The AbCellera Biologics sector is Healthcare.

AbCellera Biologics ABCL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN 1704.47 GBP 2179.91 USD
0
1704.47 GBP 2179.91 USD 1704.47 GBP 2179.91 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD